COVID-19 Update

As a team with a rich antiviral heritage, we have undertaken expansive efforts to unravel SARS-CoV-2 biology and directed our discovery platform to identify and develop COVID-19 therapeutics.

Check back regularly for updates.

Our COVID-19 efforts and programs reside under

May 2020

Structural Biology

We published the first high-resolution X-ray crystal structure of the mysterious ORF9B protein of SARS-CoV-2.


july 2020

Mechanism of Action Studies

We revealed that famotidine, being repurposed for COVID-19 treatment, does not target anti-SARS-CoV-2 replication.


Preclinical Work ongoing

Drug Discovery

We have discovered a drug that not only targets SARS-CoV-2 replication, but also suppresses the immune-related cytokine storm associated with COVID-19 complications.

Late 2022

Broad-Spectrum & Pan-Coronavirus Therapeutic Approaches

Anticipating the threat of COVID-19 mutants and coronaviruses to public health we are uncovering prospects for the development of broad-spectrum therapeutics and vaccines.